Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms

Details for Australian Patent Application No. 2006236150 (hide)

Owner Fred Hutchinson Cancer Research Center

Inventors Roth, Mark B.; Morrison, Mike; Blackstone, Eric; Goldmark, Jesse

Agent Pizzeys

Pub. Number AU-A-2006236150

PCT Pub. Number WO2006/113914

Priority 60/762,462 26.01.06 US; 60/673,037 20.04.05 US; 60/673,295 20.04.05 US; 60/713,073 31.08.05 US; 60/731,549 28.10.05 US

Filing date 20 April 2006

Wipo publication date 26 October 2006

International Classifications

A61K 33/04 (2006.01) Medicinal preparations containing inorganic active ingredients - Sulfur, selenium or tellurium

A01N 1/00 (2006.01) Preservation of bodies of humans or animals, or plants, or parts thereof

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

Event Publications

22 November 2007 PCT application entered the National Phase

  PCT publication WO2006/113914 Priority application(s): WO2006/113914

29 November 2007 Amendment Made

  The nature of the amendment is: Add co-inventor name Miller, Dana. Delete co-inventor name Goldmark, Jesse.

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236153-Crystalline solid and amorphous forms of (-)- halofenate

2006236108-Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis